Blister packaging has emerged as the gold standard packaging alternative by majority of market players operating in the pharmaceutical sector due to which, the global blister pack pharmaceutical products market has witnessed considerable growth over the past couple of decades. This trend is expected to continue in the upcoming decade. In the current day and age, safeguarding the quality of products and protection from external factors are imperative in the packaging space due to which, players operating in the current blister pack pharmaceutical products market are increasingly focusing on innovations to gain a competitive edge in the current market landscape.
A number of packaging solutions is currently being deployed by pharmaceutical companies to improve the shelf life of tablets, pills, and a range of pharmaceutical products, including PCTFE, PVC, and thermoform blisters. The demand for blister pack pharmaceutical products is on the rise, owing to favorable packaging designs and alignment with requirements of the current pharmaceutical packaging industry. At present, major to small-scale players involved in the current pharmaceutical sector are increasingly focusing on incorporating tamper-evident and safe packaging strategies. The type of blister pack pharmaceutical products continues to vary in accord with the nature of drug.
At the back of these factors, along with increasingly compliance with regulatory requirements, the global blister pack pharmaceutical products market is expected to grow significantly during the forecast period.
In the current blister pack pharmaceutical products market landscape, market players are aiming toward the development of child-resistant packaging formats. The developed regions including North America and Europe are likely to be at the forefront in terms of market share and value owing to the robust regulatory structure and an organized pharmaceutical ecosystem. The rate at which blister pack pharmaceutical products has evolved in these regions over the past few years indicates that several market players operating in the current blister pack pharmaceutical products market are primarily focusing on research and development to produce products that are in line with the requirements of the industry.
At present, market players are also focusing on addressing various challenges related to boosting the shelf life of products, maximizing production efficiency, and catering to barriers across the value chain. Although traditional blister pack pharmaceutical products have gained worldwide acceptance across the pharmaceutical sector, shortcomings in this type of packaging, particularly in hostile conditions, could hamper the growth of the blister pack pharmaceutical products market during the forecast period.
Players involved in the current blister pack pharmaceutical products market are expected to focus on forging strategic alliances and launching new blister pack pharmaceutical products to gain a competitive edge. Moreover, customization and deployment of new manufacturing techniques to improve quality and performance are expected to remain a key differentiating factor between top tier and lower tier companies. Recent trends indicate a rise in the number of collaborations between market players in the Asia Pacific region and Europe.
For instance, Amcor entered a partnership with GSK and a machine manufacturer in Italy, CAM-Partena, to produce a robust packaging solution that offers optimum protection for products that are highly sensitive to moisture. In 2019, Tekni-Films launched the SBC 240 polyvinylidene chloride (PVDC)-coated PE film that was particularly designed as a cost-efficient alternative to other existing products in the company’s product portfolio. While product launch and collaborations are likely to continue, market players are also anticipated to focus on the choice of materials to develop high-quality products.
The COVID-19 pandemic is expected to have a strong impact on the overall growth trajectory of the global blister pack pharmaceutical products market particularly in the first half of the assessment period. Due to the increasing fear and uncertainty pertaining to the nature of the virus and its mode of transmission in the first two quarters of 2020, players involved in the current pharmaceutical sector were compelled to explore most innovative and safe packaging alternatives. The significant rise in the demand for secondary and primary packaging in a range of drug formats, including capsules, syringes, and bottles, among others, is expected to provide a solid boost to the blister pack pharmaceutical products market amid the ongoing COVID-19 pandemic.
Analysts’ Viewpoint
The global blister pack pharmaceutical products market is expected to expand at a healthy CAGR of 6.7% during the forecast period. The market growth is primarily driven by factors such as growing emphasis on improving quality and performance of existing packaging alternatives, significant rise in research and development expenditure, and entry of new packaging technologies. Market players should focus on product development and forging strategic alliances with players in other regional markets to gain a competitive edge and expand their market share.
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. TMR Analysis and Recommendations
1.4. Opportunity Analysis
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Market Viewpoint
3.1. Global Economic Outlook
3.2. Global Pharmaceutical Market Overview
3.3. Macro-Economic Factors and Co-relation Analysis
3.4. Forecast Factors – Relevance and Impact
3.5. Value Chain Analysis
3.5.1. Exhaustive List of Active Participants
3.5.1.1. Raw Material Suppliers
3.5.1.2. Manufacturers
3.5.1.3. Distributers/End Users
3.5.2. Profitability Margins
4. Impact of COVID-19
4.1.1. Current Statistics and Probable Future Impact
4.1.2. Current Economic Projection – GDP/GVA and Probable Impact
4.1.3. Comparison of SAARs and Market Recovery, for Key Countries
4.1.4. Comparison to 2008 Financial Crisis and Market Recovery, for Key Countries
4.1.5. Impact of COVID-19 on Blister Pack Pharmaceutical Products Market
5. Blister Pack Pharmaceutical Products Market Analysis
5.1. Market Value (US$ Mn) and Analysis & Forecast
5.2. Y-o-Y Growth Projections
5.3. Absolute $ Opportunity Analysis
6. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By Drug Type
6.1. Section Summary
6.2. Introduction
6.2.1. Market share and Basis Points (BPS) Analysis By Drug Type
6.2.2. Y-o-Y Growth Projections By Drug Type
6.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
6.3.1. Tablets
6.3.2. Capsules
6.4. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
6.4.1. Tablets
6.4.2. Capsules
6.5. Market Attractiveness Analysis By Drug Type
7. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By Manufacturing Process
7.1. Section Summary
7.2. Introduction
7.2.1. Market share and Basis Points (BPS) Analysis By Manufacturing Process
7.2.2. Y-o-Y Growth Projections By Manufacturing Process
7.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
7.3.1. Cold Forming
7.3.2. Thermoforming
7.4. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
7.4.1. Cold Forming
7.4.2. Thermoforming
7.5. Market Attractiveness Analysis By Manufacturing Process
8. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By End Use
8.1. Section Summary
8.2. Introduction
8.2.1. Market share and Basis Points (BPS) Analysis By End Use
8.2.2. Y-o-Y Growth Projections End Use
8.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
8.3.1. Pharmaceuticals
8.3.2. Nutraceuticals and Supplements
8.3.3. Veterinary Drugs
8.4. Market Size (US$ Mn) Forecast 2020-2030, By End Use
8.4.1. Pharmaceuticals
8.4.2. Nutraceuticals and Supplements
8.4.3. Veterinary Drugs
8.5. Market Attractiveness Analysis By End Use
9. Global Blister Pack Pharmaceutical Products Market Analysis and Forecast, By Region
9.1. Section Summary
9.2. Introduction
9.2.1. Market share and Basis Points (BPS) Analysis By Region
9.2.2. Y-o-Y Growth Projections By Region
9.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Region
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa (MEA)
9.4. Market Size (US$ Mn) Forecast 2020-2030 By Region
9.4.1. North America
9.4.2. Latin America
9.4.3. Europe
9.4.4. Asia Pacific
9.4.5. Middle East and Africa (MEA)
9.5. Market Attractiveness Analysis By Region
10. North America Blister Pack Pharmaceutical Products Market Analysis and Forecast
10.1. Section Summary
10.2. Introduction
10.2.1. Market share and Basis Points (BPS) Analysis By Country
10.2.2. Y-o-Y Growth Projections By Country
10.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
10.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
10.4.1. U.S.
10.4.2. Canada
10.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
10.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
10.6.1. Tablets
10.6.2. Capsules
10.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
10.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
10.8.1. Cold Forming
10.8.2. Thermoforming
10.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
10.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
10.10.1. Pharmaceuticals
10.10.2. Nutraceuticals and Supplements
10.10.3. Veterinary Drugs
10.11. Prominent Trends
11. Latin America Blister Pack Pharmaceutical Products Market Analysis and Forecast
11.1. Section Summary
11.2. Introduction
11.2.1. Market share and Basis Points (BPS) Analysis By Country
11.2.2. Y-o-Y Growth Projections By Country
11.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
11.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of Latin America
11.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
11.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
11.6.1. Tablets
11.6.2. Capsules
11.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
11.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
11.8.1. Cold Forming
11.8.2. Thermoforming
11.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
11.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
11.10.1. Pharmaceuticals
11.10.2. Nutraceuticals and Supplements
11.10.3. Veterinary Drugs
11.11. Prominent Trends
12. Europe Blister Pack Pharmaceutical Products Market Analysis and Forecast
12.1. Section Summary
12.2. Introduction
12.2.1. Market share and Basis Points (BPS) Analysis By Country
12.2.2. Y-o-Y Growth Projections By Country
12.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
12.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
12.4.1. Germany
12.4.2. Spain
12.4.3. Italy
12.4.4. France
12.4.5. U.K.
12.4.6. BENELUX
12.4.7. NORDIC
12.4.8. Russia
12.4.9. Poland
12.4.10. Rest of Europe
12.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
12.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
12.6.1. Tablets
12.6.2. Capsules
12.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
12.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
12.8.1. Cold Forming
12.8.2. Thermoforming
12.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
12.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
12.10.1. Pharmaceuticals
12.10.2. Nutraceuticals and Supplements
12.10.3. Veterinary Drugs
12.11. Prominent Trends
13. Asia Pacific Blister Pack Pharmaceutical Products Market Analysis and Forecast
13.1. Section Summary
13.2. Introduction
13.2.1. Market share and Basis Points (BPS) Analysis By Country
13.2.2. Y-o-Y Growth Projections By Country
13.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
13.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
13.4.1. China
13.4.2. India
13.4.3. Japan
13.4.4. ASEAN
13.4.5. Australia and New Zealand
13.4.6. Rest of APAC
13.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
13.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
13.6.1. Tablets
13.6.2. Capsules
13.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
13.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
13.8.1. Cold Forming
13.8.2. Thermoforming
13.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
13.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
13.10.1. Pharmaceuticals
13.10.2. Nutraceuticals and Supplements
13.10.3. Veterinary Drugs
13.11. Prominent Trends
14. Middle East and Africa Blister Pack Pharmaceutical Products Market Analysis and Forecast
14.1. Section Summary
14.2. Introduction
14.2.1. Market share and Basis Points (BPS) Analysis By Country
14.2.2. Y-o-Y Growth Projections By Country
14.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
14.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
14.4.1. GCC countries
14.4.2. Northern Africa
14.4.3. South Africa
14.4.4. Turkey
14.4.5. Rest of MEA
14.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
14.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
14.6.1. Tablets
14.6.2. Capsules
14.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
14.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
14.8.1. Cold Forming
14.8.2. Thermoforming
14.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
14.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
14.10.1. Pharmaceuticals
14.10.2. Nutraceuticals and Supplements
14.10.3. Veterinary Drugs
14.11. Prominent Trends
15. Market Structure Analysis
15.1. Market Analysis, by Tier of Companies
15.2. Market Concentration
15.3. Market Presence Analysis
16. Competitive Landscape
16.1. Competition Dashboard
16.2. Company Market Share Analysis
16.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments, SWOT analysis)
16.4. Competition Deep Dive
16.4.1.1. Pfizer Inc
16.4.1.1.1. Overview
16.4.1.1.2. Product Portfolio
16.4.1.1.3. Profitability
16.4.1.1.4. Sales Footprint
16.4.1.1.5. Competition Benchmarking
16.4.1.1.6. Strategy
16.4.1.1.6.1. Marketing Strategy
16.4.1.1.6.2. Product Strategy
16.4.1.1.6.3. Channel Strategy
16.4.1.2. GlaxoSmithKline plc
16.4.1.2.1. Overview
16.4.1.2.2. Product Portfolio
16.4.1.2.3. Profitability
16.4.1.2.4. Sales Footprint
16.4.1.2.5. Competition Benchmarking
16.4.1.2.6. Strategy
16.4.1.2.6.1. Marketing Strategy
16.4.1.2.6.2. Product Strategy
16.4.1.2.6.3. Channel Strategy
16.4.1.3. Sanofi
16.4.1.3.1. Overview
16.4.1.3.2. Product Portfolio
16.4.1.3.3. Profitability
16.4.1.3.4. Sales Footprint
16.4.1.3.5. Competition Benchmarking
16.4.1.3.6. Strategy
16.4.1.3.6.1. Marketing Strategy
16.4.1.3.6.2. Product Strategy
16.4.1.3.6.3. Channel Strategy
16.4.1.4. Roche Holding AG
16.4.1.4.1. Overview
16.4.1.4.2. Product Portfolio
16.4.1.4.3. Profitability
16.4.1.4.4. Sales Footprint
16.4.1.4.5. Competition Benchmarking
16.4.1.4.6. Strategy
16.4.1.4.6.1. Marketing Strategy
16.4.1.4.6.2. Product Strategy
16.4.1.4.6.3. Channel Strategy
16.4.1.5. Novartis AG
16.4.1.5.1. Overview
16.4.1.5.2. Product Portfolio
16.4.1.5.3. Profitability
16.4.1.5.4. Sales Footprint
16.4.1.5.5. Competition Benchmarking
16.4.1.5.6. Strategy
16.4.1.5.6.1. Marketing Strategy
16.4.1.5.6.2. Product Strategy
16.4.1.5.6.3. Channel Strategy
16.4.1.6. Allergan
16.4.1.6.1. Overview
16.4.1.6.2. Product Portfolio
16.4.1.6.3. Profitability
16.4.1.6.4. Sales Footprint
16.4.1.6.5. Competition Benchmarking
16.4.1.6.6. Strategy
16.4.1.6.6.1. Marketing Strategy
16.4.1.6.6.2. Product Strategy
16.4.1.6.6.3. Channel Strategy
16.4.1.7. Johnson & Johnson
16.4.1.7.1. Overview
16.4.1.7.2. Product Portfolio
16.4.1.7.3. Profitability
16.4.1.7.4. Sales Footprint
16.4.1.7.5. Competition Benchmarking
16.4.1.7.6. Strategy
16.4.1.7.6.1. Marketing Strategy
16.4.1.7.6.2. Product Strategy
16.4.1.7.6.3. Channel Strategy
16.4.1.8. Merck
16.4.1.8.1. Overview
16.4.1.8.2. Product Portfolio
16.4.1.8.3. Profitability
16.4.1.8.4. Sales Footprint
16.4.1.8.5. Competition Benchmarking
16.4.1.8.6. Strategy
16.4.1.8.6.1. Marketing Strategy
16.4.1.8.6.2. Product Strategy
16.4.1.8.6.3. Channel Strategy
16.4.1.9. Sun Pharmaceutical Industries Ltd
16.4.1.9.1. Overview
16.4.1.9.2. Product Portfolio
16.4.1.9.3. Profitability
16.4.1.9.4. Sales Footprint
16.4.1.9.5. Competition Benchmarking
16.4.1.9.6. Strategy
16.4.1.9.6.1. Marketing Strategy
16.4.1.9.6.2. Product Strategy
16.4.1.9.6.3. Channel Strategy
16.4.1.10. Cadila Healthcare
16.4.1.10.1. Overview
16.4.1.10.2. Product Portfolio
16.4.1.10.3. Profitability
16.4.1.10.4. Sales Footprint
16.4.1.10.5. Competition Benchmarking
16.4.1.10.6. Strategy
16.4.1.10.6.1. Marketing Strategy
16.4.1.10.6.2. Product Strategy
16.4.1.10.6.3. Channel Strategy
17. Assumptions and Acronyms
18. Research Methodology
List of Tables
Table 01: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 02: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 03: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 04: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Region
Table 05: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 06: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 07: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 08: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 09: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 10: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 11: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 12: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 13: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 14: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 15: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 16: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 17: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 18: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 19: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 20: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 21: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 22: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 23: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 24: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country value (US$ Bn) 2015H-2030F, by Drug Type
List of Figures
Figure 01: Global Blister Pack Pharmaceutical Products Market Share by Drug Type (2020E & 2030F)
Figure 02: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Drug Type, 2020E-2028F
Figure 03: Global Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
Figure 04: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
Figure 05: Global Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
Figure 06: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
Figure 07: Global Blister Pack Pharmaceutical Products Market Share by Region (2020E & 2030F)
Figure 08: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Region, 2020E-2028F
Figure 09: North America Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)
Figure 10: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F
Figure 11: North America Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
Figure 12: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
Figure 13: North America Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
Figure 14: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
Figure 15: North America Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)
Figure 16: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F
Figure 17: Latin America Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)
Figure 18: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F
Figure 19: Latin America Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
Figure 20: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
Figure 21: Latin America Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
Figure 22: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
Figure 23: Latin America Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)
Figure 24: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F
Figure 25: Europe Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)
Figure 26: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F
Figure 27: Europe Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
Figure 28: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
Figure 29: Europe Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
Figure 30: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
Figure 31: Europe Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)
Figure 32: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F
Figure 33: Asia Pacific Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)
Figure 34: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F
Figure 35: Asia Pacific Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
Figure 36: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
Figure 37: Asia Pacific Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
Figure 38: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
Figure 39: Asia Pacific Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)
Figure 40: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F
Figure 41: MEA Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)
Figure 42: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F
Figure 43: MEA Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
Figure 44: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
Figure 45: MEA Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
Figure 46: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
Figure 47: MEA Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)
Figure 48: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Blister Pack Pharmaceutical Products Market
